Request infomation-Bio-Equip in China

Home > Request Information

Title:	Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14
* Company:
* Country:
* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Message:
Verification Code:	refresh